POC test device for capillary blood samples, 3/13:76
Sarstedt’s Minivette POCT is a device for the precise and hygienic collection, transfer, and subsequent dispensing of small capillary blood samples for point-of-care tests.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
HPLC columns, 3/13:76
Thermo Fisher Scientific’s Syncronis high-performance liquid chromatography columns are now available with 3-mm particle size. The new size complements the existing 1.7- and 5-µm particle sizes.
Horizon Discovery named ‘most promising’ at conference, 3/13:76
Horizon Discovery was named the most promising company at the Personalized Medicine World Conference 2013. Horizon was chosen from 32 shortlisted companies based on technology, historical performance of the company, and forward business plans.
Yellow HRP stain, 3/13:76
Diagnostic BioSystems’ PermaYellow/horseradish peroxidase (HRP) is a substrate-chromogen system designed for immunohistochemistry or in situ hybridization when using horseradish peroxidase. PermaYellow/HRP produces a distinct bright yellow color that can be distinguished easily from other stains.
Liquid-handling extraction products, 3/13:76
Akonni Biosystems has extended its family of smart-tip extraction products for rapidly purifying human genomic deoxyribonucleic acid (gDNA) on Hamilton’s Microlab Star robotic liquid-handling workstations.
Five percent oxalic acid, 3/13:76
Used in conjunction with Alpha-Tec Systems’ NAC-PAC (N-acetylcysteinepackage ) line of digestion/ decontamination, buffering, and resuspension reagents, Alpha-Tec’s five percent oxalic acid is recommended to optimize decontamination conditions of specimens with P. aeruginosa.
Dako, Lilly to collaborate, 3/13:76
Dako, an Agilent Technologies company, has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investigational oncology medicine currently under development by Lilly.
Mycology reference guide, 3/13
Mycology Benchtop Reference Guide is an illustrated guide to common fungi. Included are full-color colony and microscopic views. The guide provides a convenient way for students and medical technologists to quickly and confidently identify fungi.
Qiagen adds biomarkers for personalized health care, 3/13:75
Qiagen announced three separate agreements that add biomarkers to its diagnostic pipeline for personalized health care applications to guide treatments with various medicines based on a patient’s genomic information.
PerkinElmer, Verinata to expand access to prenatal test, 3/13:75
PerkinElmer and Verinata Health announced a strategic agreement for expanding access to Verinata’s Verifi test, a comprehensive noninvasive prenatal test (NIPT) for high-risk pregnancies. The Verifi test, performed at Verinata’s CLIA-certified California laboratory, uses a single maternal blood draw at as early as 10 weeks of pregnancy to detect multiple fetal chromosomal aneuploidies. Under terms of the collaboration, PerkinElmer will serve as an exclusive Verinata partner in joint sales and marketing of the Verifi test.